Abbott, GSK Collaborate on Lung Cancer Test

Abbott will develop a PCR-based test for an antigen in non-small cell lung cancer tumors for a GSK drug candidate.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.